NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Mar 2019
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Clinical Trials (1)
Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study
Started Jul 2025
40 enrolled
Alcohol Use Disorder (AUD)Post Traumatic Stress Disorder (PTSD)
Loss of Exclusivity
LOE Date
Mar 8, 2037
134 months away
Patent Expiry
Mar 8, 2037
External Resources